ATAD2 predicts poor outcomes in patients with ovarian cancer and is a marker of proliferation

Qun Liu(Beijing Anzhen Hospital), Jian Liu(Nantong University)
International Journal of Oncology
November 14, 2019
Cited by 33


Related Papers